Ufr Medecine Urca
Reims, 51100, France
NCT Number: NCT07437495
In France, the number of unintended or unwanted pregnancies remains a public health issue, often leading to voluntary termination of pregnancy. This issue is, moreover, one of the priorities of the national sexual health strategy launched by the Ministry of Social Affairs and Health for the period from 2017 to 2030.
The postpartum period (ranging from 0 to 24 months) is recognized as a high-risk period for unplanned pregnancies, which may result in voluntary termination of pregnancy. This observation raises questions about the effectiveness of prevention and information policies regarding postpartum fertility and the various contraceptive methods.
Better information and the use of regular contraception, or recourse to emergency contraception, could help reduce the number of unwanted pregnancies during the postpartum period.
This study is active but is not currently recruiting participants.
18 year and older
Female
Observational
Reims, 51100, France
The primary objective is to describe women's knowledge regarding contraception in the postpartum period, particularly emergency contraception
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
data collection
Time frame: Day 0
Women's knowledge regarding contraception in the postpartum period (0-24 months after childbirth) assessed by a questionnaire developed by a working group composed of midwives, methodologists and a data manager. The questions will address the different contraceptive methods and their possible use in the postpartum period, as well as knowledge concerning the risk of pregnancy during the postpartum period.
Université de Reims Champagne-Ardenne
Other
Acronym: CO CT-PP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial DetailsNCT02146950
Contraception
Berlin, Germany
View Trial DetailsNCT05174884
Contraception
Santo Domingo, DN, Dominican Republic
View Trial DetailsNCT06299475
Contraception
Stockholm, Sweden
View Trial Details